STOCK VALUATION IMPROVEMENT OF PT. KALBE FARMA, TBK, A CASE STUDY OF COVID-19 VACCINE PRODUCTION FOR NATIONAL VACCINATION PROGRAM
PT. Kalbe Farma, Tbk (KLBF) is a pharmaceutical company in Indonesia and has been listed on the Indonesia Stock Exchange since 1991. KLBF’s revenue is much influenced by the sale of prescription drugs, over the counter drugs, and consumer health products, especially during the pandemic. In order to...
Saved in:
Main Author: | Kurniawan Wijaya, Indra |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/57889 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
STOCK VALUATION AND BUSINESS PERFORMANCE OF INDONESIA PHARMACEUTICAL COMPANY AMIDST COVID-19 PANDEMIC (CASE STUDY OF PT. KALBE FARMA, TBK.)
by: Ericko Setiawan, Gideon -
Analisis strategi bersaing PT Kalbe Farma Tbk
by: , ELLIYAS, et al.
Published: (2010) -
VALUASI NILAI INTRINSIK SAHAM PT KALBE FARMA TBK (KLBF)
by: , Asasih Sophia Handadari, et al.
Published: (2012) -
UNDERSTANDING THE DIFFERENCE IN RECIPIENTS' PERCEPTION ON CORPORATE SOCIAL RESPONSIBILITY PROGRAM IN EDUCATION CONDUCTED BY PT KALBE FARMA TBK
by: Yolanda, Michelle -
NEW BUSINESS STRATEGY FOR PT KALBE FARMA TBK TO BECOME THE MARKET LEADER IN THE PSYCHIATRY SECTOR IN INDONESIA
by: Erwin